CIM Investment Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9,589
| Closed | -$246K | – | 251 |
|
|
2022
Q3 | $246K | Hold |
9,589
| – | – | 0.11% | 178 |
|
|
2022
Q2 | $228K | Hold |
9,589
| – | – | 0.09% | 191 |
|
|
2022
Q1 | $216K | Sell |
9,589
-1,124
| -10% | -$25.3K | 0.07% | 224 |
|
|
2021
Q4 | $212K | Hold |
10,713
| – | – | 0.06% | 276 |
|
|
2021
Q3 | $211K | Hold |
10,713
| – | – | 0.07% | 278 |
|
|
2021
Q2 | $236K | Hold |
10,713
| – | – | 0.07% | 261 |
|
|
2021
Q1 | $255K | Sell |
10,713
-643
| -6% | -$15.3K | 0.08% | 240 |
|
|
2020
Q4 | $297K | Hold |
11,356
| – | – | 0.1% | 208 |
|
|
2020
Q3 | $198K | Sell |
11,356
-11,034
| -49% | -$192K | 0.08% | 240 |
|
|
2020
Q2 | $377K | Sell |
22,390
-5,412
| -19% | -$91.1K | 0.15% | 135 |
|
|
2020
Q1 | $331K | Buy |
27,802
+9,091
| +49% | +$108K | 0.16% | 126 |
|
|
2019
Q4 | $226K | Sell |
18,711
-14,620
| -44% | -$177K | 0.09% | 191 |
|
|
2019
Q3 | $471K | Hold |
33,331
| – | – | 0.18% | 135 |
|
|
2019
Q2 | $372K | Sell |
33,331
-695
| -2% | -$7.76K | 0.14% | 186 |
|
|
2019
Q1 | $399K | Sell |
34,026
-289
| -0.8% | -$3.39K | 0.15% | 177 |
|
|
2018
Q4 | $458K | Buy |
34,315
+17,602
| +105% | +$235K | 0.2% | 114 |
|
|
2018
Q3 | $234K | Hold |
16,713
| – | – | 0.08% | 299 |
|
|
2018
Q2 | $263K | Buy |
+16,713
| New | +$263K | 0.09% | 294 |
|